BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
8/6/2020 9:52:05 AM | Browse: 399 | Download: 885
 |
Received |
|
2020-03-04 12:06 |
|
Peer-Review Started |
|
2020-03-04 12:06 |
 |
To Make the First Decision |
|
|
|
Return for Revision |
|
2020-04-14 18:09 |
|
Revised |
|
2020-06-02 08:41 |
|
Second Decision |
|
2020-06-22 09:45 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Company Editor-in-Chief |
|
2020-06-23 01:26 |
|
Articles in Press |
|
2020-06-23 01:26 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
2020-07-14 08:29 |
|
Typeset the Manuscript |
|
2020-08-04 06:09 |
|
Publish the Manuscript Online |
|
2020-08-06 09:52 |
| ISSN |
2307-8960 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2020. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Medicine, Research & Experimental |
| Manuscript Type |
Observational Study |
| Article Title |
Dydrogesterone treatment for menstrual-cycle regularization in abnormal uterine bleeding – ovulation dysfunction patients
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Lu Wang, Hai-Yun Guan, He-Xia Xia, Xiu-Ying Chen and Wei Zhang |
| ORCID |
|
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| Abbott (32F Crio's Plaza, 388 West Nanjing Road, Shanghai, China) |
A14-390 |
|
| Corresponding Author |
Wei Zhang, MD, Professor, Department of Reproductive Endocrinology, Obstetrics and Gynecology Hospital of Fudan University, No. 419 Fangxie Road, Shanghai 200011, China. zhangwei623@hotmail.com |
| Key Words |
Dydrogesterone; Abnormal uterine bleeding-ovulation dysfunction; Menstrual cycle; Hormone; Testosterone; Dehydroepiandrosterone sulfate |
| Core Tip |
The normal interval of menstrual-cycle is typically 21 to 35 d and duration of normal menstrual flow is generally 5 d. Abnormal uterine bleeding continues to pose significant physical and financial burdens on patients. In the study, we analyzed the data that 114 women with abnormal uterine bleeding - ovulation dysfunction had been prescribed dydrogesterone and treated with dydrogesterone 10 mg from day 16 to day 25 of each cycle, being consecutive at least 3 cycles. Based on these data, suggested that dydrogesterone therapy was effective in achieving menstrual-cycle regularization for Chinese patients with abnormal uterine bleeding-ovulation dysfunction. |
| Publish Date |
2020-08-06 09:52 |
| Citation |
Wang L, Guan HY, Xia HX, Chen XY, Zhang W. Dydrogesterone treatment for menstrual-cycle regularization in abnormal uterine bleeding – ovulation dysfunction patients. World J Clin Cases 2020; 8(15): 3259-3266 |
| URL |
https://www.wjgnet.com/2307-8960/full/v8/i15/3259.htm |
| DOI |
https://dx.doi.org/10.12998/wjcc.v8.i15.3259 |
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
